Positive data from two pooled post-hoc analyses of phase III ORION trials of inclisiran Nov. 16, 2020
Denali achieves biomarker proof of concept for transport vehicle technology with DNL-310 Nov. 13, 2020
Phase I/II data with PKU gene therapy HMI-102 show marked reductions in Phe at two doses Nov. 10, 2020
Regeneron pauses dosing in phase II trial of garetosmab for fibrodysplasia ossificans progressiva Nov. 3, 2020
RSS